Churg-Strauss syndrome associated with zafirlukast

Journal of the American Osteopathic Association

Volumn 98, Issue 5, 1998, Pages 275-278

  Holloway, Jennifer ^a   Ferriss, John ^b   Groff, James ^b   Craig, Timothy J ^b,d   Klinik, Michelle ^c  

^a PENN STATE MILTON S HERSHEY MEDICAL CENTER   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c Family Center for Allergy   (United States)

^d PENN STATE COLLEGE OF MEDICINE   (United States)

Author keywords

Allergic angiitis and granulomatosis; Asthma; Churg Strauss syndrome; Leukotriene modifiers; Oral Corticosteroid; Zafirlukast

Indexed keywords

AMOXICILLIN PLUS CLAVULANIC ACID; BECLOMETASONE DIPROPIONATE; BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CALCIUM; CLARITHROMYCIN; CORTICOSTEROID; FLUTICASONE PROPIONATE; LEUKOTRIENE; LEUKOTRIENE RECEPTOR BLOCKING AGENT; METHOTREXATE; MONTELUKAST; PAROXETINE; PRANLUKAST; PREDNISONE; SALBUTAMOL SULFATE; SALMETEROL XINAFOATE; THEOPHYLLINE; VITAMIN D; ZAFIRLUKAST; ZILEUTON;

ADULT; ARTICLE; ASTHMA; CASE REPORT; CHURG STRAUSS SYNDROME; CORTICOSTEROID THERAPY; DIABETES MELLITUS; DISEASE COURSE; EOSINOPHILIA; FEMALE; GASTROINTESTINAL SYMPTOM; GRANULOMATOSIS; HEADACHE; HISTOPATHOLOGY; HUMAN; NECROTIZING ARTERITIS; OBESITY; ORAL DRUG ADMINISTRATION; PROGNOSIS;

ADULT; ANTI-ASTHMATIC AGENTS; ANTI-INFLAMMATORY AGENTS; CHURG-STRAUSS SYNDROME; DRUG THERAPY, COMBINATION; HUMANS; IMMUNOSUPPRESSIVE AGENTS; LEUKOTRIENE ANTAGONISTS; MALE; METHOTREXATE; METHYLPREDNISOLONE; TOSYL COMPOUNDS;

EID: 0031837079     PISSN: 00986151     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Sly RM. Changing asthma mortality and sales of inhaled bronchodilators and anti-asthmatic drugs. Ann Allergy 1994;73:439-443.
2. Guidelines for Diagnosis and Management of Asthma. Expert Panel Report 2. Bethesda, Md: National Institutes of Health; NIH Publication No. 97-4051A; 1997.
3. FDA Talk Paper. T97-34; July 23, 1997.
4. Wechsler ME, Garpestad E, Flier SR, Kocher O, Weiland DA, Polito AJ, et al. Pulmonary infiltrates, eosinophila, and cardiomyopathy following corticosteroid withdrawal in patients with asthma receiving zafirlukast. JAMA 1998;279: 455-457
5. Spector SL. Leukotriene inhibitors and antagonists in asthma. Ann Allergy Asthma Immunol 1995;75:463-473.
6. Holgate ST, Bradding P, Sampson AP. Leukotriene antagonists and synthesis inhibitors: New directions in asthma therapy. J Allergy Clin Immunol 1996;98:1-13
7. Churg J, Strauss L: Allergic granulomatosis, allergic angiitis and periarteritis nodosa. Am J Pathol 1951;27:277-301.
8. Jennette JC, Falk RJ, Andrassy K, Bacon PA, Churg J, Gross WL, et al. Nomenclature of systemic vasculitides: Proposal of an International Consensus Conference. Arthritis Rheum 1994,37:187-192.
9. Fauci AS. Vasculitis. J Allergy Immunol 1983; 72;221-223.
10. Leavitt RY, Fauci AS. Pulmonary vasculitis. Rev Respir Dis 1986;134:149-166.
11. Stockman G Die Stellung des ChurgStrauss Syndrome zwischen anderen hypereosinophilia, granulomatosen und vaskulitischen erkrankunger. Rheumatologie 1988;47: 388-396.
12. Galperin C, Hoffman GS. Antineutrophil cytoplasmic antibodies in Wegener's granulomatosis and other diseases: Clinical issues. Cleve Clin J Med 1994;61:416-427.
13. Churg A, Brallas M, Cronin SR, Churg J. Forme frustes of Churg-Strauss syndrome. Chest 1995;108:320-323.
14. Hubner C, Dietz A, Stremmel W, et al. Macrolide induced Churg-Strauss syndrome in a patient with atopy. Letter Lancet 1997; 350: 563.